Ingersoll Rand Inc. · IR · FY2026 Q3 · Calendar Q4 2026

Ingersoll Rand raises FY2026 outlook as orders accelerate

Ingersoll Rand's Q3 supports a constructive operating trajectory: organic orders accelerated, margins improved sequentially, and management raised FY2026 guidance. The thesis remains dependent on converting data-center demand without lasting margin dilution and navigating China pricing pressure.

Reported After market closeNYSEIndustrials $30.99B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.07 Consensus $0.90
EPS surprise +18.5% Reported versus consensus
Reported revenue $2.06B Consensus $2.05B
Revenue surprise +0.6% Reported versus consensus

Market reaction

event-close to next-session close
Stock move +0.2% Event window
SPY move -1.8% Same window
Abnormal move +2.1% Stock minus SPY
Volume 0.8× Versus trailing sessions
Subsequent drift 0.0% Up to 20 sessions
IRSPY benchmark

Ask FN2 about IR FY2026 Q3

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management reported stronger organic orders, raised FY2026 revenue and EPS guidance, expanded the share-repurchase authorization, and highlighted its first large engineered-to-order data-center solution. The IVEK acquisition added another precision-technology growth avenue.

Guidance delta

FY2026 revenue and EPS guidance were raised.

Key takeaways

  • Organic orders grew faster than organic revenue, pointing to a stronger forward order environment.
  • Margins improved sequentially despite China pricing pressure and inflationary headwinds.
  • The $195 million data-center order opens a new engineered-to-order market opportunity.
  • IVEK, disciplined bolt-on M&A, and expanded repurchase authorization broaden the capital-allocation plan.

Management priorities

  • Scale engineered-to-order data-center offerings across regions.
  • Execute disciplined bolt-on acquisitions in precision liquid metering and related technologies.
  • Use the IRX framework to improve productivity and margins while maintaining disciplined capital allocation.

Follow IR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
IR EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 2 future estimate-only quarters. Q2 '24 estimate $0.78 Q2 '24 actual $0.83, beat Q3 '24 estimate $0.82 Q3 '24 actual $0.84, beat Q2 '25 estimate $0.80 Q2 '25 actual $0.80, match Q3 '25 estimate $0.86 Q3 '25 actual $0.86, match Q4 '25 estimate $0.91 Q4 '25 actual $0.96, beat Q1 '26 estimate $0.74 Q1 '26 actual $0.77, beat Q2 '26 estimate $0.83 Q2 '26 actual $0.86, beat Q3 '26 estimate $0.90 Q3 '26 actual $1.07, beat Q4 '26 estimate $1.00 Q1 '27 estimate $0.80
Show 2 more >

Analyst Consensus ?

ConsensusBuy15 ratings
Bullish853.3%
Neutral746.7%
Bearish00.0%

Analyst 52W Price Targets

$79.86Current
$50Low
$77.55Average
$110High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Evercore ISI Group In Line In LineMaintainAug 11, 2026
Baird Outperform OutperformMaintainAug 3, 2026
Stifel Hold HoldMaintainJul 20, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJun 3, 2026
Wells Fargo Overweight OverweightMaintainApr 30, 2026
Citigroup Buy BuyMaintainApr 30, 2026
Barclays Overweight OverweightMaintainApr 30, 2026
Goldman Sachs Buy BuyMaintainDec 12, 2024
CFRA Hold HoldMaintainAug 2, 2024
UBS Buy BuyMaintainJan 29, 2024
Deutsche Bank Hold HoldMaintainApr 12, 2023
Credit Suisse Neutral NeutralMaintainNov 4, 2022
Jefferies Buy BuyMaintainJul 15, 2022
Wolfe Research Peer Perform OutperformDowngradeApr 6, 2022
Vertical Research Buy HoldUpgradeJun 17, 2021
Show less

Named analyst price targets

Upside is calculated against the persisted current price $79.86. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Stifel NicolausNathan Jones$93$77.78 +16.5%Oct 19, 2026
Morgan StanleyChristopher Snyder$87$87 +8.9%Aug 10, 2026
Stifel NicolausAnalyst unavailable$84$82.24 +5.2%Jul 20, 2026
Morgan StanleyChristopher Snyder$80$71.7 +0.2%Jun 3, 2026
Evercore ISIDavid Raso$84$75.31 +5.2%May 11, 2026
Robert W. BairdAnalyst unavailable$103$77.46 +29.0%Apr 30, 2026
BarclaysAnalyst unavailable$95$77.46 +19.0%Apr 30, 2026
Stifel NicolausAnalyst unavailable$90$87.69 +12.7%Apr 14, 2026
Robert W. BairdAnalyst unavailable$115$98.52 +44.0%Feb 17, 2026
BarclaysAnalyst unavailable$111$98.52 +39.0%Feb 17, 2026
Wells FargoJoseph O'Dea$110$98.52 +37.7%Feb 17, 2026
Stifel NicolausNathan Jones$87$87.27 +8.9%Jan 23, 2026
Wells FargoJoseph O'Dea$92$83.43 +15.2%Jan 7, 2026
Stifel NicolausAnalyst unavailable$81$79.88 +1.4%Dec 16, 2025
Robert W. BairdAnalyst unavailable$100$76.33 +25.2%Nov 3, 2025
Stifel NicolausAnalyst unavailable$79$77.22 -1.1%Oct 20, 2025
Stifel NicolausAnalyst unavailable$78$78.6 -2.3%Aug 4, 2025
Melius ResearchRob Wertheimer$93$89.02 +16.5%Jul 14, 2025
Stifel NicolausNathan Jones$77$73.37 -3.6%Apr 14, 2025
BarclaysJulian Mitchell$93$81.38 +16.5%Mar 26, 2025
BarclaysAnalyst unavailable$96$85.22 +20.2%Mar 10, 2025
BarclaysJulian Mitchell$115$89.16 +44.0%Jan 8, 2025
Wells FargoJoseph O'Dea$105$89.16 +31.5%Jan 7, 2025
BarclaysJulian Mitchell$105$98 +31.5%Oct 2, 2024
Morgan StanleyChris Snyder$97$87.61 +21.5%Sep 6, 2024
Stifel NicolausNathan Jones$101$87.76 +26.5%Aug 2, 2024
BarclaysJulian Mitchell$101$91.23 +26.5%Aug 2, 2024
Robert W. BairdMichael Halloran$109$86.72 +36.5%May 6, 2024
Wells FargoAnalyst unavailable$60$53.22 -24.9%Jan 5, 2023
BarclaysAnalyst unavailable$60$53.41 -24.9%Jan 5, 2023
JefferiesStephen Volkmann$55$44.55 -31.1%Jul 26, 2022
Deutsche BankAnalyst unavailable$50$41.04 -37.4%Jul 13, 2022
Goldman SachsAnalyst unavailable$50$41.76 -37.4%Jun 23, 2022
Morgan StanleyJoshua Pokrzywinski$52$49.33 -34.9%Jun 7, 2022
Credit SuisseAnalyst unavailable$52$43.8 -34.9%May 6, 2022
Goldman SachsJoe Ritchie$68$57.1 -14.9%Nov 4, 2021
CitigroupAndrew Kaplowitz$62$52.9 -22.4%Sep 3, 2021
Vertical ResearchJeffrey Sprague$54$45.95 -32.4%Jun 17, 2021
Evercore ISIDavid Raso$53$47.09 -33.6%May 12, 2021
Show less

Track every rating change on IR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Ingersoll Rand Inc., established in 1859 and headquartered in Davidson, North Carolina, delivers essential air, fluid, energy, medical, and specialized vehicle technologies to customers across the United States, Europe, the Middle East, Africa, and the Asia Pacific regions. The company operates through two primary divisions: Industrial Technologies and Services, and Precision and Science Technologies. The Industrial Technologies and Services division is responsible for the design, production, sales, and maintenance of various air and gas compression, vacuum, and blower solutions, alongside fluid handling and loading systems, power tools, and lifting apparatus. This segment also encompasses all related spare parts, consumables, air purification systems, controls, additional accessories, and support services.…

Historical context

All IR earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the IR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-10-30T17:05:34.708847+00:00
  2. FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
  3. Polygon adjusted daily market bars · 2026-10-30T18:00:44.375261+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T18:00:44.372440+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.